Saraiva Liliana, Duarte Catia
Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
iCBR, Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal.
Open Access Rheumatol. 2023 Jan 27;15:11-22. doi: 10.2147/OARRR.S282622. eCollection 2023.
The early identification of patients with inflammatory arthritis and their referral to rheumatologists in order to establish a diagnosis and to start treatment plays a crucial role in patient outcomes. However, it is recognized that a large proportion of patients with inflammatory arthritis are diagnosed very late, losing the opportunity to start treatment in the very early stages of disease, resulting in a worse prognosis. This delay depends on several factors related to the patient, the disease, socio-demographic and health system aspects. Over time, several strategies have been developed and implemented at different levels aiming to overcome such barriers and to reduce the time from the onset of the symptoms until the diagnosis and start of adequate treatment. In this non-systematic comprehensive review, we will describe the main barriers in the identification of patients with inflammatory arthritis at different levels. We will also discuss the different strategies that have been implemented with the objective to overcome the recognized barriers and their impact in the reduction of delays.
早期识别炎性关节炎患者并将其转诊给风湿病专家以确立诊断并开始治疗,对患者的治疗结果起着至关重要的作用。然而,人们认识到,很大一部分炎性关节炎患者被诊断得很晚,失去了在疾病早期阶段开始治疗的机会,导致预后更差。这种延迟取决于与患者、疾病、社会人口统计学和卫生系统相关的几个因素。随着时间的推移,已经在不同层面制定并实施了多种策略,旨在克服此类障碍,并缩短从症状出现到诊断及开始适当治疗的时间。在这篇非系统性的综合综述中,我们将描述在不同层面识别炎性关节炎患者时的主要障碍。我们还将讨论为克服已识别的障碍而实施的不同策略及其在减少延迟方面的影响。